211 related articles for article (PubMed ID: 17573079)
1. The kynurenic acid hypothesis of schizophrenia.
Erhardt S; Schwieler L; Nilsson L; Linderholm K; Engberg G
Physiol Behav; 2007 Sep; 92(1-2):203-9. PubMed ID: 17573079
[TBL] [Abstract][Full Text] [Related]
2. Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis.
Linderholm KR; Andersson A; Olsson S; Olsson E; Snodgrass R; Engberg G; Erhardt S
Neuropharmacology; 2007 Dec; 53(8):918-24. PubMed ID: 17959203
[TBL] [Abstract][Full Text] [Related]
3. Kynurenic acid and schizophrenia.
Erhardt S; Schwieler L; Engberg G
Adv Exp Med Biol; 2003; 527():155-65. PubMed ID: 15206728
[TBL] [Abstract][Full Text] [Related]
4. Clozapine interacts with the glycine site of the NMDA receptor: electrophysiological studies of dopamine neurons in the rat ventral tegmental area.
Schwieler L; Linderholm KR; Nilsson-Todd LK; Erhardt S; Engberg G
Life Sci; 2008 Aug; 83(5-6):170-5. PubMed ID: 18590745
[TBL] [Abstract][Full Text] [Related]
5. Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid.
Erhardt S; Engberg G
Acta Physiol Scand; 2002 May; 175(1):45-53. PubMed ID: 11982504
[TBL] [Abstract][Full Text] [Related]
6. Effects of COX-1 and COX-2 inhibitors on the firing of rat midbrain dopaminergic neurons--possible involvement of endogenous kynurenic acid.
Schwieler L; Erhardt S; Nilsson L; Linderholm K; Engberg G
Synapse; 2006 Apr; 59(5):290-8. PubMed ID: 16416446
[TBL] [Abstract][Full Text] [Related]
7. Clozapine modulates midbrain dopamine neuron firing via interaction with the NMDA receptor complex.
Schwieler L; Engberg G; Erhardt S
Synapse; 2004 May; 52(2):114-22. PubMed ID: 15034917
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory action of clozapine on rat ventral tegmental area dopamine neurons following increased levels of endogenous kynurenic acid.
Schwieler L; Erhardt S
Neuropsychopharmacology; 2003 Oct; 28(10):1770-7. PubMed ID: 12865892
[TBL] [Abstract][Full Text] [Related]
9. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
Javitt DC
Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia.
Olsson SK; Andersson AS; Linderholm KR; Holtze M; Nilsson-Todd LK; Schwieler L; Olsson E; Larsson K; Engberg G; Erhardt S
Int J Neuropsychopharmacol; 2009 May; 12(4):501-12. PubMed ID: 18796185
[TBL] [Abstract][Full Text] [Related]
11. Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia.
Erhardt S; Blennow K; Nordin C; Skogh E; Lindström LH; Engberg G
Neurosci Lett; 2001 Nov; 313(1-2):96-8. PubMed ID: 11684348
[TBL] [Abstract][Full Text] [Related]
12. Nicotine-induced excitation of locus coeruleus neurons is blocked by elevated levels of endogenous kynurenic acid.
Erhardt S; Hajos M; Lindberg A; Engberg G
Synapse; 2000 Aug; 37(2):104-8. PubMed ID: 10881031
[TBL] [Abstract][Full Text] [Related]
13. Systemically administered glucosamine-kynurenic acid, but not pure kynurenic acid, is effective in decreasing the evoked activity in area CA1 of the rat hippocampus.
Robotka H; Németh H; Somlai C; Vécsei L; Toldi J
Eur J Pharmacol; 2005 Apr; 513(1-2):75-80. PubMed ID: 15878711
[TBL] [Abstract][Full Text] [Related]
14. Presynaptic metabotropic glutamate receptors regulate glutamatergic input to dopamine neurons in the ventral tegmental area.
de Rover M; Meye FJ; Ramakers GM
Neuroscience; 2008 Jul; 154(4):1318-23. PubMed ID: 18534761
[TBL] [Abstract][Full Text] [Related]
15. Long-term exposure to nicotine markedly reduces kynurenic acid in rat brain--in vitro and ex vivo evidence.
Zielińska E; Kuc D; Zgrajka W; Turski WA; Dekundy A
Toxicol Appl Pharmacol; 2009 Oct; 240(2):174-9. PubMed ID: 19616570
[TBL] [Abstract][Full Text] [Related]
16. Kynurenate and 7-chlorokynurenate formation in chronically epileptic rats.
Wu HQ; Rassoulpour A; Goodman JH; Scharfman HE; Bertram EH; Schwarcz R
Epilepsia; 2005 Jul; 46(7):1010-6. PubMed ID: 16026552
[TBL] [Abstract][Full Text] [Related]
17. Alterations of plasma and cerebrospinal fluid glutamate levels in rats treated with the N-methyl-D-aspartate receptor antagonist, ketamine.
Tomiya M; Fukushima T; Kawai J; Aoyama C; Mitsuhashi S; Santa T; Imai K; Toyo'oka T
Biomed Chromatogr; 2006; 20(6-7):628-33. PubMed ID: 16779778
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine, a risk factor for atherosclerosis, biphasically changes the endothelial production of kynurenic acid.
Stazka J; Luchowski P; Urbanska EM
Eur J Pharmacol; 2005 Jul; 517(3):217-23. PubMed ID: 15961072
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologically elevated levels of endogenous kynurenic acid prevent nicotine-induced activation of nigral dopamine neurons.
Erhardt S; Oberg H; Engberg G
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):21-7. PubMed ID: 11191832
[TBL] [Abstract][Full Text] [Related]
20. The pentylenetetrazole-induced activity in the hippocampus can be inhibited by the conversion of L-kynurenine to kynurenic acid: an in vitro study.
Rozsa E; Robotka H; Nagy D; Farkas T; Sas K; Vecsei L; Toldi J
Brain Res Bull; 2008 Jul; 76(5):474-9. PubMed ID: 18534254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
